Experience of Rwanda on COVID-19 Case Management: From Uncertainties to the Era of Neutralizing Monoclonal Antibodies

The management of COVID-19 in Rwanda has been dynamic, and the use of COVID-19 therapeutics has gradually been updated based on scientific discoveries. The treatment for COVID-19 remained patient-centered and entirely state-sponsored during the first and second waves. From the time of identification...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkeshimana, Menelas, Igiraneza, Deborah, Turatsinze, David, Niyonsenga, Otto, Abimana, Deborah, Iradukunda, Cyprien, Bizimana, Emmanuel, Muragizi, Jean, Mumporeze, Lise, Lussungu, Laurent, Mugisha, Hackim, Mgamb, Elizabeth, Bigirimana, Noella, Rwagasore, Edison, Gatare, Swaibu, Mugabo, Hassan, Nsekuye, Olivier, Semakula, Muhammed, Sendegeya, Augustin, Rurangwa, Ephraim, Kalimba, Edgar, Musafiri, Sanctus, Ntihabose, Corneille, Seruyange, Eric, Bavuma, Charlotte, Twagirumugabe, Theogene, Nyamwasa, Daniel, Nsanzimana, Sabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834306/
https://www.ncbi.nlm.nih.gov/pubmed/35162047
http://dx.doi.org/10.3390/ijerph19031023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834306/
https://www.ncbi.nlm.nih.gov/pubmed/35162047
http://dx.doi.org/10.3390/ijerph19031023

Ejemplares similares